Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:INSP NASDAQ:LIVN NASDAQ:SIBN NYSE:WRBY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeINSPInspire Medical Systems$84.13+5.6%$124.60$73.92▼$225.00$2.36B1.221.44 million shs1.18 million shsLIVNLivaNova$50.64+2.2%$45.19$32.48▼$57.35$2.71B0.92794,516 shs632,381 shsSIBNSiBone$15.20-1.3%$17.54$11.70▼$20.05$664.37M0.91452,898 shs545,410 shsWRBYWarby Parker$24.39+5.0%$22.75$12.46▼$29.73$2.44B2.091.79 million shs1.84 million shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceINSPInspire Medical Systems+5.66%-2.29%-35.52%-45.98%-56.92%LIVNLivaNova+2.18%+18.85%+14.23%+16.28%+16.74%SIBNSiBone-1.30%-5.00%-11.63%-18.93%+7.88%WRBYWarby Parker+4.92%+0.20%+9.86%+39.92%+87.60%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationINSPInspire Medical Systems4.6692 of 5 stars4.31.00.04.82.91.71.9LIVNLivaNova2.0169 of 5 stars2.53.00.00.02.01.71.3SIBNSiBone4.0873 of 5 stars3.53.00.03.32.02.50.6WRBYWarby Parker1.9688 of 5 stars2.32.00.00.03.13.30.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceINSPInspire Medical Systems 2.54Moderate Buy$173.31106.00% UpsideLIVNLivaNova 3.00Buy$59.2917.07% UpsideSIBNSiBone 3.00Buy$23.6755.70% UpsideWRBYWarby Parker 2.58Moderate Buy$24.06-1.33% DownsideCurrent Analyst Ratings BreakdownLatest SIBN, LIVN, WRBY, and INSP Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/11/2025SIBNSiBoneCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetOverweight ➝ Overweight$25.008/8/2025WRBYWarby ParkerCowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy8/8/2025WRBYWarby ParkerUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$20.00 ➝ $23.008/8/2025WRBYWarby ParkerStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$21.00 ➝ $22.008/7/2025WRBYWarby ParkerEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingPositive ➝ Positive8/7/2025WRBYWarby ParkerTelsey Advisory GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$28.008/7/2025WRBYWarby ParkerBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$24.00 ➝ $28.008/5/2025WRBYWarby ParkerRoth CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetNeutral ➝ Neutral$24.008/5/2025INSPInspire Medical SystemsLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetBuy ➝ Buy$270.00 ➝ $150.008/5/2025INSPInspire Medical SystemsWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$174.00 ➝ $101.008/5/2025INSPInspire Medical SystemsUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetBuy ➝ Buy$270.00 ➝ $230.00(Data available from 8/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookINSPInspire Medical Systems$802.80M3.10$1.80 per share46.61$22.92 per share3.67LIVNLivaNova$1.25B2.21$4.33 per share11.69$20.56 per share2.46SIBNSiBone$167.18M3.92N/AN/A$3.95 per share3.85WRBYWarby Parker$771.32M3.33$0.36 per share68.40$3.44 per share7.09Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateINSPInspire Medical Systems$53.51M$1.7348.6326.132.456.17%10.38%8.93%N/ALIVNLivaNova$63.23M-$3.89N/A16.13N/A-16.13%14.57%6.91%10/29/2025 (Estimated)SIBNSiBone-$30.91M-$0.56N/AN/AN/A-12.83%-14.20%-10.38%N/AWRBYWarby Parker-$20.39M-$0.07N/A243.88N/A-1.12%-0.79%-0.41%N/ALatest SIBN, LIVN, WRBY, and INSP EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/6/2025Q2 2025LIVNLivaNova$0.84$1.05+$0.21$0.50$332.20 million$352.50 million8/4/2025Q2 2025INSPInspire Medical Systems$0.22$0.45+$0.23-$0.12$214.50 million$217.09 million8/4/2025Q2 2025SIBNSiBone-$0.19-$0.14+$0.05-$0.14$48.12 million$48.63 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthINSPInspire Medical SystemsN/AN/AN/AN/AN/ALIVNLivaNovaN/AN/AN/AN/AN/ASIBNSiBoneN/AN/AN/AN/AN/AWRBYWarby ParkerN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioINSPInspire Medical SystemsN/A6.144.84LIVNLivaNova0.311.291.09SIBNSiBone0.218.387.00WRBYWarby ParkerN/A2.552.30Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipINSPInspire Medical Systems94.91%LIVNLivaNova97.64%SIBNSiBone98.11%WRBYWarby Parker93.24%Insider OwnershipCompanyInsider OwnershipINSPInspire Medical Systems2.30%LIVNLivaNova0.29%SIBNSiBone3.90%WRBYWarby Parker18.24%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableINSPInspire Medical Systems1,24629.57 million28.89 millionOptionableLIVNLivaNova2,90054.60 million54.44 millionOptionableSIBNSiBone35043.14 million41.46 millionOptionableWRBYWarby Parker3,780105.19 million85.44 millionOptionableSIBN, LIVN, WRBY, and INSP HeadlinesRecent News About These CompaniesWRBY Q2 Deep Dive: Retail Expansion, AI Partnerships, and Margin Leverage Define the QuarterAugust 12 at 6:33 PM | msn.comWarby Parker Inc. (NYSE:WRBY) Shares Sold by Polen Capital Management LLCAugust 11 at 8:18 AM | marketbeat.comWarby Parker Gets Price Target Hikes On Strong Q2 Report, Google AI Glasses OptimismAugust 11 at 7:47 AM | msn.comHow Warby Parker Has Kept the Price of Glasses at $95 for 15 YearsAugust 10 at 5:30 AM | wsj.com21,662 Shares in Warby Parker Inc. (NYSE:WRBY) Acquired by XTX Topco LtdAugust 10 at 3:41 AM | marketbeat.comStifel Nicolaus Increases Warby Parker (NYSE:WRBY) Price Target to $22.00August 9, 2025 | marketbeat.comJefferies Financial Group Inc. Makes New $292,000 Investment in Warby Parker Inc. (NYSE:WRBY)August 9, 2025 | marketbeat.comZurcher Kantonalbank Zurich Cantonalbank Sells 64,236 Shares of Warby Parker Inc. (NYSE:WRBY)August 9, 2025 | marketbeat.comLoop Capital Markets Reaffirms Their Buy Rating on Warby Parker (WRBY)August 9, 2025 | theglobeandmail.comWarby Parker Shares Slip After Giving Up Early Gains Despite Strong Q2 Results and Raised OutlookAugust 8, 2025 | benzinga.comWarby Parker’s (NYSE:WRBY) Q2 Sales Top EstimatesAugust 8, 2025 | msn.comTelsey Advisory Group Reiterates "Outperform" Rating for Warby Parker (NYSE:WRBY)August 8, 2025 | marketbeat.comBTIG Research Forecasts Strong Price Appreciation for Warby Parker (NYSE:WRBY) StockAugust 8, 2025 | marketbeat.comWarby Parker (NYSE:WRBY) Sets New 52-Week High - Should You Buy?August 8, 2025 | marketbeat.comQ2 Earnings Forecast for Warby Parker Issued By Roth CapitalAugust 8, 2025 | marketbeat.comAccuvest Global Advisors Purchases Shares of 13,406 Warby Parker Inc. (NYSE:WRBY)August 8, 2025 | marketbeat.com100,791 Shares in Warby Parker Inc. (NYSE:WRBY) Purchased by AlpInvest Partners B.V.August 8, 2025 | marketbeat.comQ1 EPS Estimates for Warby Parker Decreased by Roth CapitalAugust 8, 2025 | americanbankingnews.comWarby Parker Inc. (WRBY) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | seekingalpha.comCompared to Estimates, Warby Parker (WRBY) Q2 Earnings: A Look at Key MetricsAugust 7, 2025 | zacks.comWarby Parker Inc. (WRBY) Q2 Earnings Match EstimatesAugust 7, 2025 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSIBN, LIVN, WRBY, and INSP Company DescriptionsInspire Medical Systems NYSE:INSP$84.13 +4.50 (+5.65%) Closing price 08/12/2025 03:59 PM EasternExtended Trading$83.75 -0.38 (-0.45%) As of 08/12/2025 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.LivaNova NASDAQ:LIVN$50.64 +1.08 (+2.18%) Closing price 08/12/2025 04:00 PM EasternExtended Trading$50.62 -0.02 (-0.04%) As of 08/12/2025 05:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.SiBone NASDAQ:SIBN$15.20 -0.20 (-1.30%) Closing price 08/12/2025 04:00 PM EasternExtended Trading$15.22 +0.03 (+0.16%) As of 08/12/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.Warby Parker NYSE:WRBY$24.39 +1.17 (+5.03%) Closing price 08/12/2025 03:59 PM EasternExtended Trading$24.34 -0.05 (-0.22%) As of 08/12/2025 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Warby Parker Inc. provides eyewear products in the United States and Canada. The company offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, non-prescription lenses, and contact lenses. It also provides accessories, such as cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray through its retail stores, website, and mobile apps. In addition, the company offers eye exams and vision tests. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Intel's White House Reset: From Political Storm to a Clearer Sky AST SpaceMobile on Track for Explosive Upside Oklo’s Stock Is Set up for a Correction—Buy It When It Bounces If Qualcomm Holds $145, Its Next Move Could Be Massive Alphabet Reclaims $200 Threshold—Bull Run Reignited? NFL and WWE Land on ESPN—The Impact on Disney and TKO Stocks Brutal 2025 for Sarepta—Analysts Still Call for 179% Upside Apple & Trump: $100B Investment, Tariffs News Push Shares Up 13% Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access